| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10963539 | Vaccine | 2015 | 7 Pages |
Abstract
Forty-five months after PCV13 introduction, overall IPD and PCV13-serotype IPD rates had decreased 58% and 83%, respectively, in Alaska children <5 years of age when compared with 2005-2008. We observed evidence of indirect effect among adults with a 39% reduction in IPD among persons 18-44 years.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Michael G. Bruce, Rosalyn Singleton, Lisa Bulkow, Karen Rudolph, Tammy Zulz, Prabhu Gounder, Debby Hurlburt, Dana Bruden, Thomas Hennessy,